L3VLUP
ProSign in

CDNA · ELV in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

CDNAELV
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • CDNA
  • ELV
010203040202120222023202420252026
Holders and value by quarter
QuarterCDNAELV
Q3 20206 holders, $167m30 holders, $15.0bn
Q4 20207 holders, $649m29 holders, $16.7bn
Q1 20217 holders, $671m25 holders, $18.6bn
Q2 20217 holders, $835m30 holders, $19.4bn
Q3 20214 holders, $248m26 holders, $18.5bn
Q4 20213 holders, $180m29 holders, $23.3bn
Q1 20223 holders, $144m31 holders, $23.9bn
Q2 20225 holders, $124m32 holders, $23.3bn
Q3 20223 holders, $112m34 holders, $22.6bn
Q4 20222 holders, $74m34 holders, $25.5bn
Q1 20232 holders, $67m39 holders, $22.5bn
Q2 20234 holders, $64m38 holders, $20.6bn
Q3 20234 holders, $55m34 holders, $19.8bn
Q4 20235 holders, $111m36 holders, $20.3bn
Q1 20244 holders, $83m35 holders, $21.3bn
Q2 20243 holders, $113m33 holders, $22.1bn
Q3 20245 holders, $160m30 holders, $20.2bn
Q4 20246 holders, $103m32 holders, $15.9bn
Q1 20254 holders, $55m28 holders, $17.1bn
Q2 20252 holders, $48m27 holders, $14.8bn
Q3 20252 holders, $38m27 holders, $12.7bn
Q4 20252 holders, $51m25 holders, $17.0bn
Q1 20262 holders, $49m26 holders, $13.6bn
Q2 20264 holders, $114m28 holders, $17.7bn
CDNA

Caredx Inc

Holders
5
Reported value
$111m
Buyers
4
Sellers
0

Breadth +4 among 93 comparable managers.

Health care services and research
ELV

Elevance Health Inc Formerly

Holders
36
Reported value
$20.3bn
Buyers
10
Sellers
27

Breadth -17 among 93 comparable managers.

Health care services and researchManaged care

Who holds both, Q4 2023

Among the 39 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only CDNA (3)

ARK Investment Management LLC, Brevan Howard Capital Management LP, Caxton Associates LLP

Only ELV (34)

AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Artisan Partners LP, Baillie Gifford & Co, Bridgewater Associates LP, Citadel Advisors LLC, D. E. Shaw & Co., D1 Capital Partners LP, Dodge & Cox, ExodusPoint Capital Management LP, Fidelity (FMR LLC), Glenview Capital Management LLC, Invesco Ltd, Janus Henderson Group Ltd, Man Group PLC, Marshall Wace LLP, Maverick Capital Ltd, MFS Investment Management, Millennium Management LLC, Neuberger Berman Group LLC, Point72 Asset Management LP, Quantbot Technologies LP, Renaissance Technologies LLC, Ruane Cunniff & Goldfarb LP, and 9 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →